For the active substances fosetyl, phenmedipham and spinosad, for the purposes of assessment of the approval criteria set out in points 3.6.5 and 3.8.2 of Annex II to Regulation (EC) No 1107/2009 as amended by Commission Regulation (EU) 2018/605 [Commission Regulation (EU) 2018/605 of 19 April 2018 amending Annex II to Regulation (EC) No 1107/2009 by setting out scientific criteria for the determination of endocrine disrupting properties (OJ L 101, 20.4.2018, p. 33, ELI: http://data.europa.eu/eli/reg/2018/605/oj).], and in accordance with Article 14(1a) of Commission Implementing Regulation (EU) No 844/2012 [Commission Implementing Regulation (EU) No 844/2012 of 18 September 2012 setting out the provisions necessary for the implementation of the renewal procedure for active substances, as provided for in Regulation (EC) No 1107/2009 of the European Parliament and of the Council concerning the placing of plant protection products on the market (OJ L 252, 19.9.2012, p. 26, ELI: http://data.europa.eu/eli/reg_impl/2012/844/oj).], the Authority needs additional time to issue the conclusion related to those approval criteria. Additional time is also necessary for the Commission to adopt the ensuing risk management decisions.
Recital 29, Regulation (EU) 2025/99
In forcesince 21 Jan 2025